
Complete the assessment
Answer a short intake about your goals, health history, current weight-loss situation, and state so the right medication conversation can be surfaced first.
GLP-1 weight-loss assessment
Answer a short assessment to understand whether semaglutide or tirzepatide is the better conversation to start with, what provider review actually means, and what the next step looks like if you continue.
No commitment required to start the assessment.
Provider review required before any prescription path.
State availability may vary during launch. Current launch focus: FL.
This helps us route your assessment to the right provider workflow. Provider review is still required before any prescription path.
“I dropped weight much faster than I expected, my energy came back quickly, and the whole process was simple, clear, and well paced.”

Ava Mitchell
“I feel lighter, I move better, and my energy is way more consistent now. The process was quick, organized, and easy to stick with.”

Ryan Bennett
“The weight started coming off sooner than I thought it would, I feel much better in myself, and everything was fast, smooth, and easy.”

Maya Collins
“My workouts feel better, my body feels leaner, and I have much more control over my health now. The whole process was efficient and easy to maintain.”

Elena Brooks
“I lost the weight I had been stuck with for years, my energy is better every day, and the process moved quickly without feeling complicated.”

Lucas Moreira
“I saw real changes on the scale early, I feel healthier and more confident now, and the whole experience was clear, fast, and well run.”

Chloe Hayes
“I started losing weight within the first few weeks, I feel healthier and more confident now, and the process was easy to manage throughout.”

Nina Carter
“Being more comfortable in my body again has made a huge difference, and my confidence is back. The whole process was quick, clear, and handled really well.”

Isla Morgan
Who it’s for
This page is for people considering a medically guided weight-loss path who want to understand the medication options, prescription requirements, and next steps before they move deeper into the process.

Provider-guided GLP-1 path
Evolou is designed to bridge the gap between early research and a real clinical next step. It is not a generic peptide page, and it is not a promise of treatment. It is a cleaner way to understand whether a GLP-1 weight-loss path is worth pursuing.

Who this suits
You want a medically guided weight-loss option instead of trial-and-error
You are comparing semaglutide and tirzepatide and want help understanding the difference
You want to know what provider review changes before you share more information
You want pricing and next-step clarity before booking, paying, or committing
Medication clarity first
Use the page to understand whether semaglutide or tirzepatide is the more relevant starting discussion.
Prescription path second
The assessment explains the path, but a licensed provider still decides whether treatment is appropriate.
Fewer unknowns before you continue
State availability, price context, and partner-dependent support details are surfaced earlier so the page feels more credible.
How it works
Answer a short intake about your goals, health history, and state
See whether semaglutide or tirzepatide is the better starting conversation
Continue into licensed provider review if you want to move forward
Receive prescription guidance only if the provider decides treatment is appropriate
Get the next instructions for fulfillment, follow-up, and support based on the active partner path
Educational calculator
This tool shows how percentage-based weight loss changes the scale at your current weight. It does not predict your personal outcome, and it should only be used as context before you decide whether to continue to provider review.
Set your current weight
Choose an illustrative response range
Use the estimate to frame the assessment, not to predict your result
Current weight
Move the slider
Sample range style
Illustrative loss range
Example ending range
Educational estimate only. This calculator does not determine eligibility, predict results, or guarantee any treatment outcome. Provider review is required before any prescription path.
No commitment is required to complete the assessment. Prescription requires provider review, and state availability may vary.
Medication paths
The page should help you understand what each option is generally used for, who it may fit, and what still depends on provider review before you move forward.
Provider-reviewed GLP-1 option
A familiar GLP-1 path for adults who want to start with one of the best-known prescription options used in weight-management conversations.
Starting price
Pricing shown after assessment
Best for
People who already expect semaglutide to be the first option discussed
Prescription medication that requires licensed provider review
Often a strong starting conversation for people prioritizing familiarity and broad market availability
Final fit depends on your health history, goals, dosing needs, and partner setup
Dual-action GLP-1/GIP option
A second major prescription path for adults who want to compare semaglutide with a dual-action option before deciding what to pursue.
Starting price
Pricing shown after assessment
Best for
People who want to evaluate tirzepatide alongside semaglutide before moving forward
Prescription medication that requires licensed provider review
Useful for people who want a more informed semaglutide-versus-tirzepatide decision
Availability, dosing, and final pricing depend on the active partner and your provider-reviewed fit
What’s included

A licensed provider reviews the information before any prescription decision is made, so the page sets expectations around fit instead of implying instant approval.

Guidance on whether semaglutide or tirzepatide is the better conversation to start with, plus what each path generally means before you move forward.

Clearer language around what may happen after approval, including where refill timing, follow-up, and support depend on the active partner setup.

A cleaner explanation of what affects cost, including medication path, dose, branded versus cash-pay realities, insurance involvement, and partner setup.
What happens next
This section is here to reduce anxiety. It shows what the quiz leads to, what a provider actually decides, and where partner-dependent details start to matter.
End result
A clearer decision, a provider-reviewed next step, and fewer unknowns before you commit.
The goal is not to manufacture urgency. The goal is to help you understand the real process before prescription, fulfillment, or follow-up enter the picture.

Answer a short intake about your goals, health history, current weight-loss situation, and state so the right medication conversation can be surfaced first.

Use the result to understand whether semaglutide or tirzepatide is the better starting discussion and what that path is generally meant for.

If you continue, a licensed provider reviews your intake. That review determines whether a prescription path is appropriate rather than the quiz deciding for you.

If the provider approves treatment, you move into the next instructions for prescription, onboarding, and fulfillment based on the active partner workflow.

From there, the experience depends on the partner setup in your state, including medication fulfillment, follow-up, refill timing, and support expectations.

Why this page exists
Most weight-loss pages jump straight to the prescription pitch. Evolou is built to do the job that usually happens before that: help you understand whether a medically guided GLP-1 path is worth pursuing, which medication conversation makes more sense to start with, and what provider review actually changes.
Understand the semaglutide versus tirzepatide decision before you move forward
See what provider review, prescription requirements, and state availability mean in practice
Move into the next step with fewer surprises around pricing, timing, and support
Ready when you are
If you are serious about exploring a GLP-1 weight-loss path, the fastest way to reduce confusion is to complete the intake and see which conversation you should actually be having first.
FAQ
Want a clearer answer on fit, medication path, and what happens next? Start the assessment.